{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:03Z","timestamp":1792801383638,"version":"4.5.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Basic Research Program - Joint Project of Kunming Medical Universit","award":["202301AY070001-249"],"award-info":[{"award-number":["202301AY070001-249"]}],"id":[{"id":"https:\/\/ror.org\/038c3w259","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yunnan Provincial Department of Science and Technology Foundation for Youths","award":["202301AU070195"],"award-info":[{"award-number":["202301AU070195"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics & Chromatin"],"DOI":"10.1186\/s13072-025-00624-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:39:24Z","timestamp":1758883164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Roles of KDM5 demethylases in therapeutic resistance of cancers"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaobo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.31881","volume":"144","author":"J Plch","year":"2019","unstructured":"Plch J, Hrabeta J, Eckschlager T. KDM5 demethylases and their role in cancer cell chemoresistance. Int J Cancer. 2019;144:221\u201331. https:\/\/doi.org\/10.1002\/ijc.31881.","journal-title":"Int J Cancer"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ejmech.2018.04.012","volume":"151","author":"YS Li","year":"2018","unstructured":"Li YS, Zhao DS, Liu XY, Liao YX, Jin HW, Song GP, Cui ZN. Synthesis and biological evaluation of 2,5-disubstituted Furan derivatives as P-glycoprotein inhibitors for doxorubicin resistance in MCF-7\/ADR cell. Eur J Med Chem. 2018;151:546\u201356. https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.012.","journal-title":"Eur J Med Chem"},{"key":"624_CR3","doi-asserted-by":"publisher","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E. Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22168885.","DOI":"10.3390\/ijms22168885"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","volume":"3","author":"LV Sequist","year":"2011","unstructured":"Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3:75ra26. https:\/\/doi.org\/10.1126\/scitranslmed.3002003.","journal-title":"Sci Transl Med"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajpath.2012.05.023","volume":"181","author":"S Takeuchi","year":"2012","unstructured":"Takeuchi S, Wang W, Li Q, Yamada T, Kita K, Donev IS, Nakamura T, Matsumoto K, Shimizu E, Nishioka Y, Sone S, Nakagawa T, Uenaka T, Yano S. Dual Inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer. Am J Pathol. 2012;181:1034\u201343. https:\/\/doi.org\/10.1016\/j.ajpath.2012.05.023.","journal-title":"Am J Pathol"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1172\/jci28656","volume":"116","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borr\u00e1s AM, Gale CM, Naumov GN, Yeap BY, Jarrell E, Sun J, Tracy S, Zhao X, Heymach JV, Johnson BE, Cantley LC, J\u00e4nne PA. Allelic Dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J Clin Invest. 2006;116:2695\u2013706. https:\/\/doi.org\/10.1172\/jci28656.","journal-title":"J Clin Invest"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"113855","DOI":"10.1016\/j.ejmech.2021.113855","volume":"226","author":"GJ Yang","year":"2021","unstructured":"Yang GJ, Wu J, Miao L, Zhu MH, Zhou QJ, Lu XJ, Lu JF, Leung CH, Ma DL, Chen J. Pharmacological Inhibition of KDM5A for cancer treatment. Eur J Med Chem. 2021;226:113855. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113855.","journal-title":"Eur J Med Chem"},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"175216","DOI":"10.1016\/j.ejphar.2022.175216","volume":"931","author":"R Hai","year":"2022","unstructured":"Hai R, Yang D, Zheng F, Wang W, Han X, Bode AM, Luo X. The emerging roles of HDACs and their therapeutic implications in cancer. Eur J Pharmacol. 2022;931:175216. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175216.","journal-title":"Eur J Pharmacol"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","volume":"53","author":"F Recillas-Targa","year":"2022","unstructured":"Recillas-Targa F. Cancer epigenetics: an overview. Arch Med Res. 2022;53:732\u201340. https:\/\/doi.org\/10.1016\/j.arcmed.2022.11.003.","journal-title":"Arch Med Res"},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/nsmb.2436","volume":"19","author":"CA Musselman","year":"2012","unstructured":"Musselman CA, Lalonde ME, C\u00f4t\u00e9 J, Kutateladze TG. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol. 2012;19:1218\u201327. https:\/\/doi.org\/10.1038\/nsmb.2436.","journal-title":"Nat Struct Mol Biol"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mrrev.2017.09.003","volume":"780","author":"F Gong","year":"2019","unstructured":"Gong F, Miller KM. Histone methylation and the DNA damage response. Mutat Res Rev Mutat Res. 2019;780:37\u201347. https:\/\/doi.org\/10.1016\/j.mrrev.2017.09.003.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"624_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.06.001","author":"H Wang","year":"2024","unstructured":"Wang H, Helin K. Roles of H3K4 methylation in biology and disease. Trends Cell Biol. 2024. https:\/\/doi.org\/10.1016\/j.tcb.2024.06.001.","journal-title":"Trends Cell Biol"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/bi00889a003","volume":"3","author":"K Murray","year":"1964","unstructured":"Murray K. The occurrence of i\u03b5-N-Methyl lysine in histones. Biochemistry. 1964;3:10\u20135. https:\/\/doi.org\/10.1021\/bi00889a003.","journal-title":"Biochemistry"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13:343\u201357. https:\/\/doi.org\/10.1038\/nrg3173.","journal-title":"Nat Rev Genet"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.15252\/embr.201541113","volume":"16","author":"E Dimitrova","year":"2015","unstructured":"Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep. 2015;16:1620\u201339. https:\/\/doi.org\/10.15252\/embr.201541113.","journal-title":"EMBO Rep"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"115799","DOI":"10.1016\/j.bcp.2023.115799","volume":"216","author":"CY Li","year":"2023","unstructured":"Li CY, Liu YJ, Tao F, Chen RY, Shi JJ, Lu JF, Yang GJ, Chen J. Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy. Biochem Pharmacol. 2023;216:115799. https:\/\/doi.org\/10.1016\/j.bcp.2023.115799.","journal-title":"Biochem Pharmacol"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1038\/s41598-019-40573-y","volume":"9","author":"J Dorosz","year":"2019","unstructured":"Dorosz J, Kristensen LH, Aduri NG, Mirza O, Lousen R, Bucciarelli S, Mehta V, Sell\u00e9s-Baiget S, Solbak S, Bach A, Mesa P, Hernandez PA, Montoya G, Nguyen T, Rand KD, Boesen T, Gajhede M. Molecular architecture of the Jumonji C family histone demethylase KDM5B. Sci Rep. 2019;9:4019. https:\/\/doi.org\/10.1038\/s41598-019-40573-y.","journal-title":"Sci Rep"},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.1038\/ncomms7204","volume":"6","author":"IO Torres","year":"2015","unstructured":"Torres IO, Kuchenbecker KM, Nnadi CI, Fletterick RJ, Kelly MJ, Fujimori DG. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism. Nat Commun. 2015;6:6204. https:\/\/doi.org\/10.1038\/ncomms7204.","journal-title":"Nat Commun"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"24548","DOI":"10.1074\/jbc.M110.117333","volume":"285","author":"F Huang","year":"2010","unstructured":"Huang F, Chandrasekharan MB, Chen YC, Bhaskara S, Hiebert SW, Sun ZW. The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation. J Biol Chem. 2010;285:24548\u201361. https:\/\/doi.org\/10.1074\/jbc.M110.117333.","journal-title":"J Biol Chem"},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0968-0004(00)01700-x","volume":"26","author":"PM Clissold","year":"2001","unstructured":"Clissold PM, Ponting CP. JmjC: Cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci. 2001;26:7\u20139. https:\/\/doi.org\/10.1016\/s0968-0004(00)01700-x.","journal-title":"Trends Biochem Sci"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nsmb.1400","volume":"15","author":"S Tu","year":"2008","unstructured":"Tu S, Teng YC, Yuan C, Wu YT, Chan MY, Cheng AN, Lin PH, Juan LJ, Tsai MD. The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat Struct Mol Biol. 2008;15:419\u201321. https:\/\/doi.org\/10.1038\/nsmb.1400.","journal-title":"Nat Struct Mol Biol"},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nsmb.1753","volume":"17","author":"JR Horton","year":"2010","unstructured":"Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X. Enzymatic and structural insights for substrate specificity of a family of Jumonji histone lysine demethylases. Nat Struct Mol Biol. 2010;17:38\u201343. https:\/\/doi.org\/10.1038\/nsmb.1753.","journal-title":"Nat Struct Mol Biol"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1074\/jbc.C109.097667","volume":"285","author":"H Wen","year":"2010","unstructured":"Wen H, Li J, Song T, Lu M, Kan PY, Lee MG, Sha B, Shi X. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J Biol Chem. 2010;285:9322\u20136. https:\/\/doi.org\/10.1074\/jbc.C109.097667.","journal-title":"J Biol Chem"},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nature06034","volume":"448","author":"F Lan","year":"2007","unstructured":"Lan F, Collins RE, De Cegli R, Alpatov R, Horton JR, Shi X, Gozani O, Cheng X, Shi Y. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature. 2007;448:718\u201322. https:\/\/doi.org\/10.1038\/nature06034.","journal-title":"Nature"},{"key":"624_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41467-018-07829-z","volume":"10","author":"JE Longbotham","year":"2019","unstructured":"Longbotham JE, Chio CM, Dharmarajan V, Trnka MJ, Torres IO, Goswami D, Ruiz K, Burlingame AL, Griffin PR, Fujimori DG. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling. Nat Commun. 2019;10:94. https:\/\/doi.org\/10.1038\/s41467-018-07829-z.","journal-title":"Nat Commun"},{"key":"624_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/acs.biochem.9b01036","volume":"59","author":"N Petronikolou","year":"2020","unstructured":"Petronikolou N, Longbotham JE, Fujimori DG. Extended recognition of the histone H3 tail by histone demethylase KDM5A. Biochemistry. 2020;59:647\u201351. https:\/\/doi.org\/10.1021\/acs.biochem.9b01036.","journal-title":"Biochemistry"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"e84735","DOI":"10.1371\/journal.pone.0084735","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang S, Wang Y, Wu H, Hu L. RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer. PLoS ONE. 2013;8:e84735. https:\/\/doi.org\/10.1371\/journal.pone.0084735.","journal-title":"PLoS ONE"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"13091","DOI":"10.1002\/anie.201807305","volume":"57","author":"GJ Yang","year":"2018","unstructured":"Yang GJ, Wang W, Mok SWF, Wu C, Law BYK, Miao XM, Wu KJ, Zhong HJ, Wong CY, Wong VKW, Ma DL, Leung CH. Selective Inhibition of Lysine-Specific demethylase 5A (KDM5A) using a Rhodium(III) complex for Triple-Negative breast cancer therapy. Angew Chem Int Ed Engl. 2018;57:13091\u20135. https:\/\/doi.org\/10.1002\/anie.201807305.","journal-title":"Angew Chem Int Ed Engl"},{"key":"624_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/156802662004200304124340","volume":"20","author":"X Fu","year":"2020","unstructured":"Fu X, Yang C, Yu B. Targeting KDM5 demethylases: Inhibition and degradation. Curr Top Med Chem. 2020;20:261\u20133. https:\/\/doi.org\/10.2174\/156802662004200304124340.","journal-title":"Curr Top Med Chem"},{"key":"624_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2007.05.042","volume":"130","author":"MG Guenther","year":"2007","unstructured":"Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007;130:77\u201388. https:\/\/doi.org\/10.1016\/j.cell.2007.05.042.","journal-title":"Cell"},{"key":"624_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi.14.14","volume":"6","author":"PB Rasmussen","year":"2014","unstructured":"Rasmussen PB, Staller P. The KDM5 family of histone demethylases as targets in oncology drug discovery. Epigenomics. 2014;6:277\u201386. https:\/\/doi.org\/10.2217\/epi.14.14.","journal-title":"Epigenomics"},{"key":"624_CR32","doi-asserted-by":"publisher","first-page":"28402","DOI":"10.1074\/jbc.M100313200","volume":"276","author":"SW Chan","year":"2001","unstructured":"Chan SW, Hong W. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J Biol Chem. 2001;276:28402\u201312. https:\/\/doi.org\/10.1074\/jbc.M100313200.","journal-title":"J Biol Chem"},{"key":"624_CR33","doi-asserted-by":"publisher","first-page":"112314","DOI":"10.1016\/j.yexcr.2020.112314","volume":"396","author":"R Kirtana","year":"2020","unstructured":"Kirtana R, Manna S, Patra SK. Molecular mechanisms of KDM5A in cellular functions: facets during development and disease. Exp Cell Res. 2020;396:112314. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112314.","journal-title":"Exp Cell Res"},{"key":"624_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2007.02.013","volume":"128","author":"RJ Klose","year":"2007","unstructured":"Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG. Jr. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell. 2007;128:889\u2013900. https:\/\/doi.org\/10.1016\/j.cell.2007.02.013.","journal-title":"Cell"},{"key":"624_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-021-01041-1","volume":"14","author":"GJ Yang","year":"2021","unstructured":"Yang GJ, Zhu MH, Lu XJ, Liu YJ, Lu JF, Leung CH, Ma DL, Chen J. The emerging role of KDM5A in human cancer. J Hematol Oncol. 2021;14:30. https:\/\/doi.org\/10.1186\/s13045-021-01041-1.","journal-title":"J Hematol Oncol"},{"key":"624_CR36","doi-asserted-by":"publisher","first-page":"15633","DOI":"10.1074\/jbc.274.22.15633","volume":"274","author":"PJ Lu","year":"1999","unstructured":"Lu PJ, Sundquist K, Baeckstrom D, Poulsom R, Hanby A, Meier-Ewert S, Jones T, Mitchell M, Pitha-Rowe P, Freemont P, Taylor-Papadimitriou J. A novel gene (PLU-1) containing highly conserved putative dna\/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem. 1999;274:15633\u201345. https:\/\/doi.org\/10.1074\/jbc.274.22.15633.","journal-title":"J Biol Chem"},{"key":"624_CR37","doi-asserted-by":"publisher","first-page":"112760","DOI":"10.1016\/j.ejmech.2020.112760","volume":"208","author":"YD Fu","year":"2020","unstructured":"Fu YD, Huang MJ, Guo JW, You YZ, Liu HM, Huang LH, Yu B. Targeting histone demethylase KDM5B for cancer treatment. Eur J Med Chem. 2020;208:112760. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112760.","journal-title":"Eur J Med Chem"},{"key":"624_CR38","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ijc.10644","volume":"101","author":"A Barrett","year":"2002","unstructured":"Barrett A, Madsen B, Copier J, Lu PJ, Cooper L, Scibetta AG, Burchell J, Taylor-Papadimitriou J. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer\/testis antigen? Int J Cancer. 2002;101:581\u20138. https:\/\/doi.org\/10.1002\/ijc.10644.","journal-title":"Int J Cancer"},{"key":"624_CR39","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1038\/emboj.2011.383","volume":"30","author":"SU Schmitz","year":"2011","unstructured":"Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup N, Abarrategui I, Helin K. Jarid1b targets genes regulating development and is involved in neural differentiation. Embo J. 2011;30:4586\u2013600. https:\/\/doi.org\/10.1038\/emboj.2011.383.","journal-title":"Embo J"},{"key":"624_CR40","doi-asserted-by":"publisher","first-page":"40531","DOI":"10.1074\/jbc.M111.304865","volume":"286","author":"D Mitra","year":"2011","unstructured":"Mitra D, Das PM, Huynh FC, Jones FE. Jumonji\/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of MicroRNA let-7e. J Biol Chem. 2011;286:40531\u20135. https:\/\/doi.org\/10.1074\/jbc.M111.304865.","journal-title":"J Biol Chem"},{"key":"624_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583\u201394. https:\/\/doi.org\/10.1016\/j.cell.2010.04.020.","journal-title":"Cell"},{"key":"624_CR42","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ijc.23211","volume":"122","author":"A Roesch","year":"2008","unstructured":"Roesch A, Mueller AM, Stempfl T, Moehle C, Landthaler M, Vogt T. RBP2-H1\/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer. 2008;122:1047\u201357. https:\/\/doi.org\/10.1002\/ijc.23211.","journal-title":"Int J Cancer"},{"key":"624_CR43","first-page":"5329","volume":"8","author":"J Li","year":"2015","unstructured":"Li J, Wan X, Qiang W, Li T, Huang W, Huang S, Wu D, Li Y. MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation. Int J Clin Exp Med. 2015;8:5329\u201339.","journal-title":"Int J Clin Exp Med"},{"key":"624_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1476-4598-11-52","volume":"11","author":"F Crea","year":"2012","unstructured":"Crea F, Sun L, Mai A, Chiang YT, Farrar WL, Danesi R, Helgason CD. The emerging role of histone lysine demethylases in prostate cancer. Mol Cancer. 2012;11:52. https:\/\/doi.org\/10.1186\/1476-4598-11-52.","journal-title":"Mol Cancer"},{"key":"624_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","volume":"35","author":"D Wang","year":"2016","unstructured":"Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, Yang R, Li X. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27. J Exp Clin Cancer Res. 2016;35:37. https:\/\/doi.org\/10.1186\/s13046-016-0311-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"624_CR46","doi-asserted-by":"publisher","first-page":"12723","DOI":"10.18632\/oncotarget.3713","volume":"6","author":"B Tang","year":"2015","unstructured":"Tang B, Qi G, Tang F, Yuan S, Wang Z, Liang X, Li B, Yu S, Liu J, Huang Q, Wei Y, Zhai R, Lei B, Yu H, Jiao X, He S. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN\/AKT signaling in hepatocellular carcinoma cells. Oncotarget. 2015;6:12723\u201339. https:\/\/doi.org\/10.18632\/oncotarget.3713.","journal-title":"Oncotarget"},{"key":"624_CR47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3892\/mco.2013.127","volume":"1","author":"Y Kano","year":"2013","unstructured":"Kano Y, Konno M, Ohta K, Haraguchi N, Nishikawa S, Kagawa Y, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Ishii M, Mizohata E, Inoue T, Mori M, Doki Y, Ishii H. Jumonji\/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth. Mol Clin Oncol. 2013;1:753\u20137. https:\/\/doi.org\/10.3892\/mco.2013.127.","journal-title":"Mol Clin Oncol"},{"key":"624_CR48","first-page":"87","volume":"5","author":"Z Wang","year":"2015","unstructured":"Wang Z, Tang F, Qi G, Yuan S, Zhang G, Tang B, He S. KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis. Am J Cancer Res. 2015;5:87\u2013100.","journal-title":"Am J Cancer Res"},{"key":"624_CR49","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.1007\/s13277-015-3418-y","volume":"36","author":"X Shen","year":"2015","unstructured":"Shen X, Zhuang Z, Zhang Y, Chen Z, Shen L, Pu W, Chen L, Xu Z. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression. Tumour Biol. 2015;36:7133\u201342. https:\/\/doi.org\/10.1007\/s13277-015-3418-y.","journal-title":"Tumour Biol"},{"key":"624_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1476-4598-9-59","volume":"9","author":"S Hayami","year":"2010","unstructured":"Hayami S, Yoshimatsu M, Veerakumarasivam A, Unoki M, Iwai Y, Tsunoda T, Field HI, Kelly JD, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F\/RB pathway. Mol Cancer. 2010;9:59. https:\/\/doi.org\/10.1186\/1476-4598-9-59.","journal-title":"Mol Cancer"},{"key":"624_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcancer.2018.11.001","volume":"57","author":"B Xhabija","year":"2019","unstructured":"Xhabija B, Kidder BL. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer. Semin Cancer Biol. 2019;57:79\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2018.11.001.","journal-title":"Semin Cancer Biol"},{"key":"624_CR52","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1172\/jci140223","volume":"130","author":"JC Link","year":"2020","unstructured":"Link JC, Wiese CB, Chen X, Avetisyan R, Ronquillo E, Ma F, Guo X, Yao J, Allison M, Chen YI, Rotter JI, El-Sayed Moustafa JS, Small KS, Iwase S, Pellegrini M, Vergnes L, Arnold AP, Reue K. X chromosome dosage of histone demethylase KDM5C determines sex differences in adiposity. J Clin Invest. 2020;130:5688\u2013702. https:\/\/doi.org\/10.1172\/jci140223.","journal-title":"J Clin Invest"},{"key":"624_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-024-02011-0","volume":"23","author":"CY Li","year":"2024","unstructured":"Li CY, Wang W, Leung CH, Yang GJ, Chen J. KDM5 family as therapeutic targets in breast cancer: pathogenesis and therapeutic opportunities and challenges. Mol Cancer. 2024;23:109. https:\/\/doi.org\/10.1186\/s12943-024-02011-0.","journal-title":"Mol Cancer"},{"key":"624_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fnmol.2018.00104","volume":"11","author":"CN Vallianatos","year":"2018","unstructured":"Vallianatos CN, Farrehi C, Friez MJ, Burmeister M, Keegan CE, Iwase S. Altered Gene-Regulatory function of KDM5C by a novel mutation associated with autism and intellectual disability. Front Mol Neurosci. 2018;11:104. https:\/\/doi.org\/10.3389\/fnmol.2018.00104.","journal-title":"Front Mol Neurosci"},{"key":"624_CR55","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41375-023-01810-6","volume":"37","author":"ML Trempenau","year":"2023","unstructured":"Trempenau ML, Schuster MB, Pundhir S, Pereira MA, Kalvisa A, Tapia M, Su J, Ge Y, de Boer B, Balhuizen A, Bagger FO, Shliaha P, Sroczynska P, Walfridsson J, Gr\u00f8nb\u00e6k K, Theilgaard-M\u00f6nch K, Jensen ON, Helin K, Porse BT. The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes. Leukemia. 2023;37:593\u2013605. https:\/\/doi.org\/10.1038\/s41375-023-01810-6.","journal-title":"Leukemia"},{"key":"624_CR56","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.7150\/thno.60233","volume":"11","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Li P, Zhou X, Qiang Y, Fan J, Lin Y, Chen Y, Guo J, Wang F, Xue H, Xiong J, Li F. Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis. Theranostics. 2021;11:8674\u201391. https:\/\/doi.org\/10.7150\/thno.60233.","journal-title":"Theranostics"},{"key":"624_CR57","doi-asserted-by":"publisher","unstructured":"Lemster AL, Sievers E, Pasternack H, Lazar-Karsten P, Kl\u00fcmper N, Sailer V, Offermann A, Br\u00e4gelmann J, Perner S, Kirfel J. Histone demethylase KDM5C drives prostate cancer progression by promoting EMT. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14081894.","DOI":"10.3390\/cancers14081894"},{"key":"624_CR58","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1021\/acs.jproteome.9b00395","volume":"18","author":"A Meyfour","year":"2019","unstructured":"Meyfour A, Pahlavan S, Ansari H, Baharvand H, Salekdeh GH. Down-Regulation of a Male-Specific H3K4 demethylase, KDM5D, impairs cardiomyocyte differentiation. J Proteome Res. 2019;18:4277\u201382. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00395.","journal-title":"J Proteome Res"},{"key":"624_CR59","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1089\/scd.2020.0138","volume":"29","author":"P Pottmeier","year":"2020","unstructured":"Pottmeier P, Doszyn O, Peuckert C, Jazin E. Increased expression of Y-Encoded demethylases during differentiation of human male neural stem cells. Stem Cells Dev. 2020;29:1497\u2013509. https:\/\/doi.org\/10.1089\/scd.2020.0138.","journal-title":"Stem Cells Dev"},{"key":"624_CR60","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2443.2008.01193.x","volume":"13","author":"C Akimoto","year":"2008","unstructured":"Akimoto C, Kitagawa H, Matsumoto T, Kato S. Spermatogenesis-specific association of SMCY and MSH5. Genes Cells. 2008;13:623\u201333. https:\/\/doi.org\/10.1111\/j.1365-2443.2008.01193.x.","journal-title":"Genes Cells"},{"key":"624_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ebiom.2019.02.040","volume":"41","author":"M Mokou","year":"2019","unstructured":"Mokou M, Klein J, Makridakis M, Bitsika V, Bascands JL, Saulnier-Blache JS, Mullen W, Sacherer M, Zoidakis J, Pieske B, Mischak H, Roubelakis MG, Schanstra JP, Vlahou A. Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease. EBioMedicine. 2019;41:91\u2013104. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.040.","journal-title":"EBioMedicine"},{"key":"624_CR62","doi-asserted-by":"publisher","first-page":"114814","DOI":"10.1016\/j.bcp.2021.114814","volume":"194","author":"M Liu","year":"2021","unstructured":"Liu M, Gao N. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males. Biochem Pharmacol. 2021;194:114814. https:\/\/doi.org\/10.1016\/j.bcp.2021.114814.","journal-title":"Biochem Pharmacol"},{"key":"624_CR63","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41586-023-06254-7","volume":"619","author":"J Li","year":"2023","unstructured":"Li J, Lan Z, Liao W, Horner JW, Xu X, Liu J, Yoshihama Y, Jiang S, Shim HS, Slotnik M, LaBella KA, Wu CJ, Dunner K Jr., Hsu WH, Lee R, Khanduri I, Terranova C, Akdemir K, Chakravarti D, Shang X, Spring DJ, Wang YA, DePinho RA. Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature. 2023;619:632\u20139. https:\/\/doi.org\/10.1038\/s41586-023-06254-7.","journal-title":"Nature"},{"key":"624_CR64","doi-asserted-by":"publisher","first-page":"12453","DOI":"10.1038\/s41598-021-91907-8","volume":"11","author":"SAG Willis-Owen","year":"2021","unstructured":"Willis-Owen SAG, Domingo-Sabugo C, Starren E, Liang L, Freidin MB, Arseneault M, Zhang Y, Lu SK, Popat S, Lim E, Nicholson AG, Riazalhosseini Y, Lathrop M, Cookson WOC, Moffatt MF. Y disruption, autosomal hypomethylation and poor male lung cancer survival. Sci Rep. 2021;11:12453. https:\/\/doi.org\/10.1038\/s41598-021-91907-8.","journal-title":"Sci Rep"},{"key":"624_CR65","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.26355\/eurrev_202003_20511","volume":"24","author":"LS Cai","year":"2020","unstructured":"Cai LS, Chen QX, Fang SY, Lian MQ, Lian MJ, Cai MZ. ETV4 promotes the progression of gastric cancer through regulating KDM5D. Eur Rev Med Pharmacol Sci. 2020;24:2442\u201351. https:\/\/doi.org\/10.26355\/eurrev_202003_20511.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"624_CR66","doi-asserted-by":"publisher","first-page":"12247","DOI":"10.1002\/jcb.27308","volume":"120","author":"X Shen","year":"2019","unstructured":"Shen X, Hu K, Cheng G, Xu L, Chen Z, Du P, Zhuang Z. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male. J Cell Biochem. 2019;120:12247\u201358. https:\/\/doi.org\/10.1002\/jcb.27308.","journal-title":"J Cell Biochem"},{"key":"624_CR67","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1172\/jci96769","volume":"128","author":"K Komura","year":"2018","unstructured":"Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW. ATR Inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J Clin Invest. 2018;128:2979\u201395. https:\/\/doi.org\/10.1172\/jci96769.","journal-title":"J Clin Invest"},{"key":"624_CR68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.Can-15-0906","volume":"76","author":"N Li","year":"2016","unstructured":"Li N, Dhar SS, Chen TY, Kan PY, Wei Y, Kim JH, Chan CH, Lin HK, Hung MC, Lee MG. JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis. Cancer Res. 2016;76:831\u201343. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-0906.","journal-title":"Cancer Res"},{"key":"624_CR69","doi-asserted-by":"publisher","first-page":"114033","DOI":"10.1016\/j.biopha.2022.114033","volume":"157","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wu L, Xiao Q, Meng X, Hafiz A, Yan Q, Lu R, Cao J. Epigenetically suppressed tumor cell intrinsic STING promotes tumor immune escape. Biomed Pharmacother. 2023;157:114033. https:\/\/doi.org\/10.1016\/j.biopha.2022.114033.","journal-title":"Biomed Pharmacother"},{"key":"624_CR70","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.2147\/ijgm.S329733","volume":"14","author":"F Hao","year":"2021","unstructured":"Hao F. Systemic profiling of KDM5 subfamily signature in Non-Small-Cell lung cancer. Int J Gen Med. 2021;14:7259\u201375. https:\/\/doi.org\/10.2147\/ijgm.S329733.","journal-title":"Int J Gen Med"},{"key":"624_CR71","doi-asserted-by":"publisher","first-page":"664847","DOI":"10.3389\/fimmu.2021.664847","volume":"12","author":"XJ Chen","year":"2021","unstructured":"Chen XJ, Ren AQ, Zheng L, Zheng ED. Predictive value of KDM5C alterations for immune checkpoint inhibitors treatment outcomes in patients with cancer. Front Immunol. 2021;12:664847. https:\/\/doi.org\/10.3389\/fimmu.2021.664847.","journal-title":"Front Immunol"},{"key":"624_CR72","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.biopha.2018.08.041","volume":"107","author":"H Lin","year":"2018","unstructured":"Lin H, Yang G, Yu J, Wang J, Li Q, Guo S, Cao B. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1. Biomed Pharmacother. 2018;107:1205\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.041.","journal-title":"Biomed Pharmacother"},{"key":"624_CR73","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1073\/pnas.1600420113","volume":"113","author":"K Komura","year":"2016","unstructured":"Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, Azuma H, Lee GS, Kantoff PW, Sweeney CJ. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc Natl Acad Sci U S A. 2016;113:6259\u201364. https:\/\/doi.org\/10.1073\/pnas.1600420113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"624_CR74","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1002\/1878-0261.13314","volume":"16","author":"Y Yoshikawa","year":"2022","unstructured":"Yoshikawa Y, Stopsack KH, Wang XV, Chen YH, Mazzu YZ, Burton F, Chakraborty G, Rajanala SH, Hirani R, Nandakumar S, Lee GM, Frank D, Davicioni E, Liu G, Carducci MA, Azuma H, Kantoff PW, Sweeney CJ. Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer. Mol Oncol. 2022;16:3994\u20134010. https:\/\/doi.org\/10.1002\/1878-0261.13314.","journal-title":"Mol Oncol"},{"key":"624_CR75","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1080\/15384101.2015.1090063","volume":"14","author":"B Banelli","year":"2015","unstructured":"Banelli B, Carra E, Barbieri F, W\u00fcrth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M. The histone demethylase KDM5A is a key factor for the resistance to Temozolomide in glioblastoma. Cell Cycle. 2015;14:3418\u201329. https:\/\/doi.org\/10.1080\/15384101.2015.1090063.","journal-title":"Cell Cycle"},{"key":"624_CR76","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3892\/mmr.2017.6960","volume":"16","author":"T Feng","year":"2017","unstructured":"Feng T, Wang Y, Lang Y, Zhang Y. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance. Mol Med Rep. 2017;16:3573\u201380. https:\/\/doi.org\/10.3892\/mmr.2017.6960.","journal-title":"Mol Med Rep"},{"key":"624_CR77","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1038\/s41598-023-44536-2","volume":"13","author":"D Wang","year":"2023","unstructured":"Wang D, Zhang Y, Liao Z, Ge H, G\u00fcng\u00f6r C, Li Y. KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. Sci Rep. 2023;13:18250. https:\/\/doi.org\/10.1038\/s41598-023-44536-2.","journal-title":"Sci Rep"},{"key":"624_CR78","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/ijo.2019.4864","volume":"55","author":"C Hu","year":"2019","unstructured":"Hu C, Zhou H, Liu Y, Huang J, Liu W, Zhang Q, Tang Q, Sheng F, Li G, Zhang R. ROCK1 promotes migration and invasion of non\u2013small\u2013cell lung cancer cells through the PTEN\/PI3K\/FAK pathway. Int J Oncol. 2019;55:833\u201344. https:\/\/doi.org\/10.3892\/ijo.2019.4864.","journal-title":"Int J Oncol"},{"key":"624_CR79","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1038\/cddis.2013.519","volume":"5","author":"G Li","year":"2014","unstructured":"Li G, Liu L, Shan C, Cheng Q, Budhraja A, Zhou T, Cui H, Gao N. RhoA\/ROCK\/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo. Cell Death Dis. 2014;5:e998. https:\/\/doi.org\/10.1038\/cddis.2013.519.","journal-title":"Cell Death Dis"},{"key":"624_CR80","doi-asserted-by":"publisher","first-page":"175465","DOI":"10.1016\/j.ejphar.2022.175465","volume":"940","author":"S Fang","year":"2023","unstructured":"Fang S, Zheng L, Shen L, Su Y, Ding J, Chen W, Chen X, Chen W, Shu G, Chen M, Zhao Z, Tu J, Ji J. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1\/PTEN\/AKT pathway. Eur J Pharmacol. 2023;940:175465. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175465.","journal-title":"Eur J Pharmacol"},{"key":"624_CR81","doi-asserted-by":"publisher","unstructured":"Gaillard S, Charasson V, Ribeyre C, Salifou K, Pillaire MJ, Hoffmann JS, Constantinou A, Trouche D, Vandromme M. KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance. Biol Open. 2021;10. https:\/\/doi.org\/10.1242\/bio.057729.","DOI":"10.1242\/bio.057729"},{"key":"624_CR82","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/sj.leu.2403006","volume":"17","author":"R Hehlmann","year":"2003","unstructured":"Hehlmann R, Berger U, Pfirrmann M, Hochhaus A, Metzgeroth G, Maywald O, Hasford J, Reiter A, Hossfeld DK, Kolb HJ, L\u00f6ffler H, Pralle H, Queisser W, Griesshammer M, Nerl C, Kuse R, Tobler A, Eimermacher H, Tichelli A, Aul C, Wilhelm M, Fischer JT, Perker M, Scheid C, Schenk M, Weiss J, Meier CR, Kremers S, Labedzki L, Schmeiser T, Lohrmann HP, Heimpel H. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. Leukemia. 2003;17:1529\u201337. https:\/\/doi.org\/10.1038\/sj.leu.2403006.","journal-title":"Leukemia"},{"key":"624_CR83","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/onc.2014.155","volume":"34","author":"Y Aye","year":"2015","unstructured":"Aye Y, Li M, Long MJ, Weiss RS. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene. 2015;34:2011\u201321. https:\/\/doi.org\/10.1038\/onc.2014.155.","journal-title":"Oncogene"},{"key":"624_CR84","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard H, Garc\u00eda-Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer. 2015;15:276\u201389. https:\/\/doi.org\/10.1038\/nrc3916.","journal-title":"Nat Rev Cancer"},{"key":"624_CR85","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, K\u00f6rbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, P\u00e4tzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, Hoth M, Bastian BC, Vogt T, Herlyn M. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013;23:811\u201325. https:\/\/doi.org\/10.1016\/j.ccr.2013.05.003.","journal-title":"Cancer Cell"},{"key":"624_CR86","doi-asserted-by":"publisher","first-page":"e0125343","DOI":"10.1371\/journal.pone.0125343","volume":"10","author":"YT Kuo","year":"2015","unstructured":"Kuo YT, Liu YL, Adebayo BO, Shih PH, Lee WH, Wang LS, Liao YF, Hsu WM, Yeh CT, Lin CM. JARID1B expression plays a critical role in chemoresistance and stem Cell-Like phenotype of neuroblastoma cells. PLoS ONE. 2015;10:e0125343. https:\/\/doi.org\/10.1371\/journal.pone.0125343.","journal-title":"PLoS ONE"},{"key":"624_CR87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.dnarep.2017.10.007","volume":"60","author":"JK Horton","year":"2017","unstructured":"Horton JK, Stefanick DF, Zhao ML, Janoshazi AK, Gassman NR, Seddon HJ, Wilson SH. XRCC1-mediated repair of strand breaks independent of PNKP binding. DNA Repair (Amst). 2017;60:52\u201363. https:\/\/doi.org\/10.1016\/j.dnarep.2017.10.007.","journal-title":"DNA Repair (Amst)"},{"key":"624_CR88","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/ijbs.25881","volume":"14","author":"W Xu","year":"2018","unstructured":"Xu W, Zhou B, Zhao X, Zhu L, Xu J, Jiang Z, Chen D, Wei Q, Han M, Feng L, Wang S, Wang X, Zhou J, Jin H. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. Int J Biol Sci. 2018;14:1122\u201332. https:\/\/doi.org\/10.7150\/ijbs.25881.","journal-title":"Int J Biol Sci"},{"key":"624_CR89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2018.12.076","volume":"694","author":"L Li","year":"2019","unstructured":"Li L, Shou H, Wang Q, Liu S. Investigation of the potential theranostic role of KDM5B\/miR-29c signaling axis in Paclitaxel resistant endometrial carcinoma. Gene. 2019;694:76\u201382. https:\/\/doi.org\/10.1016\/j.gene.2018.12.076.","journal-title":"Gene"},{"key":"624_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang B, Li J, Wang Y, Liu X, Yang X, Liao Z, Deng S, Deng Y, Zhou Z, Tian Y, Wei W, Meng J, Hu Y, Wan C, Zhang Z, Huang F, Wen L, Wu B, Sun Y, Li Y, Yang K. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis. Cell Death Differ. 2024;31:309\u201321. https:\/\/doi.org\/10.1038\/s41418-024-01257-x.","journal-title":"Cell Death Differ"},{"key":"624_CR91","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1158\/2326-6066.Cir-22-0088","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Lin J, Zhou W, Moses R, Dai Z, Kossenkov AV, Drapkin R, Bitler BG, Karakashev S, Zhang R. KDM5A inhibits antitumor immune responses through downregulation of the Antigen-Presentation pathway in ovarian cancer. Cancer Immunol Res. 2022;10:1028\u201338. https:\/\/doi.org\/10.1158\/2326-6066.Cir-22-0088.","journal-title":"Cancer Immunol Res"},{"key":"624_CR92","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nm1517","volume":"13","author":"AT Parsa","year":"2007","unstructured":"Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007;13:84\u20138. https:\/\/doi.org\/10.1038\/nm1517.","journal-title":"Nat Med"},{"key":"624_CR93","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature25015","volume":"553","author":"J Zhang","year":"2018","unstructured":"Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W. Cyclin D-CDK4 kinase destabilizes PD-L1 via Cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91\u20135. https:\/\/doi.org\/10.1038\/nature25015.","journal-title":"Nature"},{"key":"624_CR94","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cell.2017.08.031","volume":"170","author":"J Haanen","year":"2017","unstructured":"Haanen J. Converting cold into hot tumors by combining immunotherapies. Cell. 2017;170:1055\u20136. https:\/\/doi.org\/10.1016\/j.cell.2017.08.031.","journal-title":"Cell"},{"key":"624_CR95","doi-asserted-by":"publisher","unstructured":"Wang L, Gao Y, Zhang G, Li D, Wang Z, Zhang J, Hermida LC, He L, Wang Z, Si J, Geng S, Ai R, Ning F, Cheng C, Deng H, Dimitrov DS, Sun Y, Huang Y, Wang D, Hu X, Wei Z, Wang W, Liao X. Enhancing KDM5A and TLR activity improves the response to immune checkpoint Blockade. Sci Transl Med. 2020;12. https:\/\/doi.org\/10.1126\/scitranslmed.aax2282.","DOI":"10.1126\/scitranslmed.aax2282"},{"key":"624_CR96","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ymthe.2022.01.003","volume":"30","author":"L Shi","year":"2022","unstructured":"Shi L, Yang Y, Li M, Li C, Zhou Z, Tang G, Wu L, Yao Y, Shen X, Hou Z, Jia H. LncRNA IFITM4P promotes immune escape by up-regulating PD-L1 via dual mechanism in oral carcinogenesis. Mol Ther. 2022;30:1564\u201377. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.003.","journal-title":"Mol Ther"},{"key":"624_CR97","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1158\/0008-5472.Can-10-2442","volume":"71","author":"M Rao","year":"2011","unstructured":"Rao M, Chinnasamy N, Hong JA, Zhang Y, Zhang M, Xi S, Liu F, Marquez VE, Morgan RA, Schrump DS. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. Cancer Res. 2011;71:4192\u2013204. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-2442.","journal-title":"Cancer Res"},{"key":"624_CR98","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, Duggan R, Wang Y, Barber GN, Fitzgerald KA, Alegre ML, Gajewski TF. STING-dependent cytosolic DNA sensing mediates innate immune recognition of Immunogenic tumors. Immunity. 2014;41:830\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.017.","journal-title":"Immunity"},{"key":"624_CR99","doi-asserted-by":"publisher","first-page":"e2006134","DOI":"10.1371\/journal.pbio.2006134","volume":"16","author":"L Wu","year":"2018","unstructured":"Wu L, Cao J, Cai WL, Lang SM, Horton JR, Jansen DJ, Liu ZZ, Chen JF, Zhang M, Mott BT, Pohida K, Rai G, Kales SC, Henderson MJ, Hu X, Jadhav A, Maloney DJ, Simeonov A, Zhu S, Iwasaki A, Hall MD, Cheng X, Shadel GS, Yan Q. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018;16:e2006134. https:\/\/doi.org\/10.1371\/journal.pbio.2006134.","journal-title":"PLoS Biol"},{"key":"624_CR100","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"SM Zhang","year":"2021","unstructured":"Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, McGeary MK, Song E, Blenman KRM, Micevic G, Jessel S, Zhang Y, Yin M, Booth CJ, Jilaveanu LB, Damsky W, Sznol M, Kluger HM, Iwasaki A, Bosenberg MW, Yan Q. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature. 2021;598:682\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03994-2.","journal-title":"Nature"},{"key":"624_CR101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13027-016-0049-x","volume":"11","author":"S Gao","year":"2016","unstructured":"Gao S, Li S, Ma Z, Liang S, Shan T, Zhang M, Zhu X, Zhang P, Liu G, Zhou F, Yuan X, Jia R, Potempa J, Scott DA, Lamont RJ, Wang H, Feng X. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11:3. https:\/\/doi.org\/10.1186\/s13027-016-0049-x.","journal-title":"Infect Agent Cancer"},{"key":"624_CR102","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fimmu.2017.00255","volume":"8","author":"CD Kramer","year":"2017","unstructured":"Kramer CD, Genco CA, Microbiota. Immune subversion, and chronic inflammation. Front Immunol. 2017;8:255. https:\/\/doi.org\/10.3389\/fimmu.2017.00255.","journal-title":"Front Immunol"},{"key":"624_CR103","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1158\/2326-6066.Cir-18-0709","volume":"7","author":"X Yuan","year":"2019","unstructured":"Yuan X, Liu Y, Li G, Lan Z, Ma M, Li H, Kong J, Sun J, Hou G, Hou X, Ma Y, Ren F, Zhou F, Gao S. Blockade of Immune-Checkpoint B7-H4 and lysine demethylase 5B in esophageal squamous cell carcinoma confers protective immunity against P. gingivalis infection. Cancer Immunol Res. 2019;7:1440\u201356. https:\/\/doi.org\/10.1158\/2326-6066.Cir-18-0709.","journal-title":"Cancer Immunol Res"},{"key":"624_CR104","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13205-021-03018-w","volume":"12","author":"H Wu","year":"2022","unstructured":"Wu H, Xu L, Hu X. KDM5A regulates the growth and gefitinib drug resistance against human lung adenocarcinoma cells. 3 Biotech. 2022;12:97. https:\/\/doi.org\/10.1007\/s13205-021-03018-w.","journal-title":"3 Biotech"},{"key":"624_CR105","doi-asserted-by":"publisher","first-page":"39931","DOI":"10.18632\/oncotarget.9539","volume":"7","author":"M Gale","year":"2016","unstructured":"Gale M, Sayegh J, Cao J, Norcia M, Gareiss P, Hoyer D, Merkel JS, Yan Q. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance. Oncotarget. 2016;7:39931\u201344. https:\/\/doi.org\/10.18632\/oncotarget.9539.","journal-title":"Oncotarget"},{"key":"624_CR106","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1586\/14737140.3.4.563","volume":"3","author":"PF Cartron","year":"2003","unstructured":"Cartron PF, Juin P, Oliver L, Meflah K, Vallette FM. Impact of proapoptotic proteins Bax and bak in tumor progression and response to treatment. Expert Rev Anticancer Ther. 2003;3:563\u201370. https:\/\/doi.org\/10.1586\/14737140.3.4.563.","journal-title":"Expert Rev Anticancer Ther"},{"key":"624_CR107","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/1541-7786.Mcr-17-0637","volume":"16","author":"Y Lu","year":"2018","unstructured":"Lu Y, Liu Y, Oeck S, Glazer PM. Hypoxia promotes resistance to EGFR Inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1. Mol Cancer Res. 2018;16:1458\u201369. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-17-0637.","journal-title":"Mol Cancer Res"},{"key":"624_CR108","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejca.2018.12.024","volume":"109","author":"B Shannan","year":"2019","unstructured":"Shannan B, Matschke J, Chauvistr\u00e9 H, Vogel F, Klein D, Meier F, Westphal D, Bruns J, Rauschenberg R, Utikal J, Forschner A, Berking C, Terheyden P, Dabrowski E, Gutzmer R, Rafei-Shamsabadi D, Meiss F, Heinzerling L, Zimmer L, Livingstone E, V\u00e1raljai R, Hoewner A, Horn S, Klode J, Stuschke M, Scheffler B, Marchetto A, Sannino G, Gr\u00fcnewald TGP, Schadendorf D, Jendrossek V, Roesch A. Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) Inhibition in melanoma. Eur J Cancer. 2019;109:137\u201353. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.024.","journal-title":"Eur J Cancer"},{"key":"624_CR109","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1535-7163.Mct-18-0395","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu X, Zhang SM, McGeary MK, Krykbaeva I, Lai L, Jansen DJ, Kales SC, Simeonov A, Hall MD, Kelly DP, Bosenberg MW, Yan Q. KDM5B promotes drug resistance by regulating Melanoma-Propagating cell subpopulations. Mol Cancer Ther. 2019;18:706\u201317. https:\/\/doi.org\/10.1158\/1535-7163.Mct-18-0395.","journal-title":"Mol Cancer Ther"},{"key":"624_CR110","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/cad.0000000000001329","volume":"33","author":"J Liu","year":"2022","unstructured":"Liu J, Nie C. KDM5B regulates the PTEN\/PI3K\/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma. Anticancer Drugs. 2022;33:840\u20139. https:\/\/doi.org\/10.1097\/cad.0000000000001329.","journal-title":"Anticancer Drugs"},{"key":"624_CR111","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","volume":"34","author":"K Hinohara","year":"2018","unstructured":"Hinohara K, Wu HJ, Vigneau S, McDonald TO, Igarashi KJ, Yamamoto KN, Madsen T, Fassl A, Egri SB, Papanastasiou M, Ding L, Peluffo G, Cohen O, Kales SC, Lal-Nag M, Rai G, Maloney DJ, Jadhav A, Simeonov A, Wagle N, Brown M, Meissner A, Sicinski P, Jaffe JD, Jeselsohn R, Gimelbrant AA, Michor F, Polyak K. KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance. Cancer Cell. 2018;34:939\u2013e953939. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.014.","journal-title":"Cancer Cell"},{"key":"624_CR112","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell. 2021;81:3677\u201390. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.015.","journal-title":"Mol Cell"},{"key":"624_CR113","doi-asserted-by":"publisher","first-page":"216605","DOI":"10.1016\/j.canlet.2023.216605","volume":"583","author":"T Sun","year":"2024","unstructured":"Sun T, Liu B, Cao Y, Li Y, Cai L, Yang W. AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy. Cancer Lett. 2024;583:216605. https:\/\/doi.org\/10.1016\/j.canlet.2023.216605.","journal-title":"Cancer Lett"},{"key":"624_CR114","doi-asserted-by":"publisher","unstructured":"Pippa S, Mannironi C, Licursi V, Bombardi L, Colotti G, Cundari E, Mollica A, Coluccia A, Naccarato V, La Regina G, Silvestri R, Negri R. Small molecule inhibitors of KDM5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B. Molecules. 2019;24. https:\/\/doi.org\/10.3390\/molecules24091739.","DOI":"10.3390\/molecules24091739"},{"key":"624_CR115","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2017.12.035","volume":"418","author":"Q Yu","year":"2018","unstructured":"Yu Q, Dong L, Li Y, Liu G. SIRT1 and HIF1\u03b1 signaling in metabolism and immune responses. Cancer Lett. 2018;418:20\u20136. https:\/\/doi.org\/10.1016\/j.canlet.2017.12.035.","journal-title":"Cancer Lett"},{"key":"624_CR116","doi-asserted-by":"publisher","first-page":"553733","DOI":"10.3389\/fcell.2020.553733","volume":"8","author":"LM Xu","year":"2020","unstructured":"Xu LM, Yu H, Yuan YJ, Zhang J, Ma Y, Cao XC, Wang J, Zhao LJ, Wang P. Overcoming of radioresistance in Non-small cell lung cancer by microRNA-320a through HIF1\u03b1-Suppression mediated methylation of PTEN. Front Cell Dev Biol. 2020;8:553733. https:\/\/doi.org\/10.3389\/fcell.2020.553733.","journal-title":"Front Cell Dev Biol"},{"key":"624_CR117","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.celrep.2018.09.081","volume":"25","author":"J Bayo","year":"2018","unstructured":"Bayo J, Tran TA, Wang L, Pe\u00f1a-Llopis S, Das AK, Martinez ED. Jumonji inhibitors overcome radioresistance in cancer through changes in H3K4 methylation at Double-Strand breaks. Cell Rep. 2018;25:1040\u2013e10501045. https:\/\/doi.org\/10.1016\/j.celrep.2018.09.081.","journal-title":"Cell Rep"},{"key":"624_CR118","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/jrr\/rrac004","volume":"63","author":"X Wang","year":"2022","unstructured":"Wang X, Gu M, Ju Y, Zhou J. Overcoming radio-resistance in esophageal squamous cell carcinoma via hypermethylation of PIK3C3 promoter region mediated by KDM5B loss. J Radiat Res. 2022;63:331\u201341. https:\/\/doi.org\/10.1093\/jrr\/rrac004.","journal-title":"J Radiat Res"}],"container-title":["Epigenetics & Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00624-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-025-00624-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00624-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:39:25Z","timestamp":1758883165000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-025-00624-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s13072-025-00624-3","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}